ZOLL Medical Appoints New CEO to Drive Growth

ZOLL Medical, a leader in medical devices and a subsidiary of Asahi Kasei, will welcome Eric Knudsen as its new Chief Executive Officer on April 1, following the decade-long tenure of Jon Rennert. Knudsen’s strategic expertise and extensive medtech experience are expected to bolster ZOLL’s growth, potentially impacting the broader medical technology industry.

Eric Knudsen’s appointment as CEO comes after his significant contributions to ZOLL, where he led Corporate Development and ZOLL Itamar. His role in advancing business development and corporate strategy laid the groundwork for his upcoming leadership. ZOLL is known internationally for its innovations in cardiopulmonary and respiratory care, with a diverse product line that includes defibrillators and monitoring systems. Jon Rennert’s shift to Executive Chairman follows a successful era of expansion, positioning ZOLL as a global frontrunner in medical technology. Knudsen’s leadership promises to further this momentum by leveraging his nearly 30 years of industry experience, including roles at Covidien and Aspect Medical Systems. 

As Eric Knudsen takes the helm at ZOLL Medical, the company stands poised for continued innovation and expansion in the medical technology sector. His proven track record and visionary approach ensure that ZOLL’s commitment to improving patient outcomes remains paramount. This leadership transition marks an exciting new chapter for ZOLL and its stakeholders.